日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of cardiometabolic risk awareness among patients with psoriasis: A quality improvement survey study

银屑病患者心血管代谢风险意识特征分析:一项质量改进调查研究

Kearney, Caitlin A; Saha, Sreejan; Mata Vivas, Maria Teresa; Gelfand, Joel M; Garelik, Jessica; Lo Sicco, Kristen I; Garshick, Michael

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

对评估硼替佐米+来那度胺+地塞米松或硼替佐米+沙利度胺+地塞米松诱导治疗适合移植的新诊断多发性骨髓瘤患者的随机对照试验进行综合分析

Rosiñol, Laura; Hebraud, Benjamin; Oriol, Albert; Colin, Anne-Laurène; Ríos Tamayo, Rafael; Hulin, Cyrille; Blanchard, María Jesús; Caillot, Denis; Sureda, Anna; Hernández, Miguel Teodoro; Arnulf, Bertrand; Mateos, Maria-Victoria; Macro, Margaret; San-Miguel, Jesús; Belhadj, Karim; Lahuerta, Juan José; Garelik, M Brigid; Bladé, Joan; Moreau, Philippe

Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol

评估吸烟相关动脉粥样硬化性心血管疾病患者肺癌患病率的流行病学研究:PREVALUNG 研究方案

Boulate, David; Fidelle, Marine; Caramella, Caroline; Issard, Justin; Planché, Olivier; Pradère, Pauline; Garelik, Daniel; Hache, Océane; Lamrani, Lilia; Zins, Marc; Beaussier, Hélène; Chatellier, Gilles; Fadel, Elie; Zitvogel, Laurence; Besse, Benjamin; Mercier, Olaf

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

DASISION 5 年研究的最终结果:达沙替尼与伊马替尼治疗初治慢性粒细胞白血病患者的研究试验

Cortes, Jorge E; Saglio, Giuseppe; Kantarjian, Hagop M; Baccarani, Michele; Mayer, Jiří; Boqué, Concepción; Shah, Neil P; Chuah, Charles; Casanova, Luis; Bradley-Garelik, Brigid; Manos, George; Hochhaus, Andreas

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

纳武利尤单抗治疗复发或难治性血液系统恶性肿瘤患者:一项 Ib 期研究的初步结果

Lesokhin, Alexander M; Ansell, Stephen M; Armand, Philippe; Scott, Emma C; Halwani, Ahmad; Gutierrez, Martin; Millenson, Michael M; Cohen, Adam D; Schuster, Stephen J; Lebovic, Daniel; Dhodapkar, Madhav; Avigan, David; Chapuy, Bjoern; Ligon, Azra H; Freeman, Gordon J; Rodig, Scott J; Cattry, Deepika; Zhu, Lili; Grosso, Joseph F; Bradley Garelik, M Brigid; Shipp, Margaret A; Borrello, Ivan; Timmerman, John

Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase

在DASISION试验中,达沙替尼与伊马替尼在东亚人群中治疗新诊断慢性期慢性粒细胞白血病的疗效和安全性比较

Chuah, Charles T; Nakamae, Hirohisa; Shen, Zhixiang X; Bradley-Garelik, M Brigid; Kim, Dong-Wook

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

达沙替尼或伊马替尼治疗新诊断的慢性期慢性粒细胞白血病:一项随机 3 期试验的 2 年随访 (DASISION)

Kantarjian, Hagop M; Shah, Neil P; Cortes, Jorge E; Baccarani, Michele; Agarwal, Mohan B; Undurraga, María Soledad; Wang, Jianxiang; Ipiña, Juan Julio Kassack; Kim, Dong-Wook; Ogura, Michinori; Pavlovsky, Carolina; Junghanss, Christian; Milone, Jorge H; Nicolini, Franck E; Robak, Tadeusz; Van Droogenbroeck, Jan; Vellenga, Edo; Bradley-Garelik, M Brigid; Zhu, Chao; Hochhaus, Andreas